Abstract
Surgical resection is the cornerstone of the management of operable patients with stage I and II non-small-cell lung cancer. Surgical approaches have evolved from open thoracotomy to mini-invasive surgery, including video-assisted thoracic surgery (VATS) and robot-assisted thoracic surgery (RATS), with a clear benefit in terms of postoperative pain, respiratory complications, and hospital length of stay. Surgical resection should include anatomic resection of the parenchyma and systematic lymph node dissection. For stage I and II disease, and operable patients, lobectomy remains the most widely used procedure. In the subset of patients with stage I tumors measuring less than 2 cm, segmentectomy is acceptable for patients with compromised lung function, multiple tumors, and in ground-glass predominant lesions. Recent trials suggest that segmentectomy might also be acceptable for patients with solid predominant stage I tumors measuring less than 2 cm, but confirmatory trial is pending, and guidelines have not evolved yet.1877-1203/© 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
